CytoDyn Inc (OTCMKTS:CYDY) CEO Nader Pourhassan tells Proactive that an abstract on the potential of its drug candidate leronlimab for the prevention of HIV has been accepted for presentation at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Pourhassan says acceptance of the abstract as late-breaking reflects leronlimab’s significant assistance in HIV prevention.
0 Comments